| 337 | Humans |
| 277 | Lymphedema |
| 237 | Female |
| 196 | Human |
| 141 | Treatment |
| 128 | Middle Aged |
| 127 | Adult |
| 126 | Male |
| 106 | Aged |
| 84 | Lymphedema (etiology) |
| 70 | Complication |
| 57 | Lymphedema (therapy) |
| 53 | Malignant tumor |
| 52 | Case study |
| 51 | Upper limb |
| 45 | Lymphedema (diagnosis) |
| 45 | Child |
| 44 | Lower limb |
| 43 | Drainage |
| 42 | Aged, 80 and over |
| 41 | Mammary gland |
| 41 | Breast Neoplasms (surgery) |
| 40 | Lymphedema (complications) |
| 40 | Dermatology |
| 39 | Surgery |
| 38 | Kinesitherapy |
| 37 | Cardiovascular disease |
| 35 | Retrospective Studies |
| 35 | Prognosis |
| 35 | Diagnosis |
| 34 | Lymphedema (pathology) |
| 33 | Review |
| 33 | Adolescent |
| 32 | Treatment Outcome |
| 32 | Follow-Up Studies |
| 31 | Lymphedema (surgery) |
| 31 | Lymphedema (diagnostic imaging) |
| 31 | Arm |
| 31 | Animals |
| 30 | Technique |
| 30 | Lymphatic system |
| 30 | Diagnosis, Differential |
| 28 | Syndrome |
| 28 | Leg |
| 28 | Breast cancer |
| 25 | Lymph Node Excision (adverse effects) |
| 25 | Limb |
| 24 | Risk Factors |
| 23 | Breast Neoplasms (pathology) |
| 22 | Time Factors |
| 22 | Prospective Studies |
| 22 | Lymphedema (genetics) |
| 22 | Exploration |
| 22 | Breast Neoplasms (radiotherapy) |
| 21 | Radiotherapy |
| 21 | Infant |
| 20 | Young Adult |
| 20 | Physiotherapy |
| 19 | Skin |
| 19 | Lymph Node Excision (methods) |
| 19 | Compression |
| 19 | Breast Neoplasms (therapy) |
| 18 | Prevention |
| 18 | Erysipelas |
| 18 | Axilla |
| 17 | Lymphedema (physiopathology) |
| 17 | Lymphatic |
| 17 | Combined Modality Therapy |
| 16 | Infant, Newborn |
| 16 | Child, Preschool |
| 16 | Chemotherapy |
| 16 | Bandages |
| 15 | Scintigraphy |
| 15 | Physical Therapy Modalities |
| 15 | Indication |
| 15 | Chronic Disease |
| 14 | Treatment efficiency |
| 14 | Skin Neoplasms (pathology) |
| 14 | Risk factor |
| 14 | Neoplasm Staging |
| 14 | Mastectomy |
| 14 | Lymphoscintigraphy |
| 14 | Chronic |
| 13 | Restraint |
| 13 | Postoperative |
| 13 | Lymphatic Metastasis |
| 13 | Breast Neoplasms (complications) |
| 13 | Angiosarcoma |
| 12 | Severity of Illness Index |
| 12 | Radionuclide Imaging |
| 12 | Postoperative Complications (etiology) |
| 12 | Breast |
| 12 | Breast Neoplasms (drug therapy) |
| 12 | Arm (pathology) |
| 11 | Tomography, X-Ray Computed |
| 11 | Pathophysiology |
| 11 | Massage |
| 11 | Lymphatic vessel disease |
| 11 | Lymph Nodes (transplantation) |
| 11 | France |
| 11 | Elderly |
| 11 | Age Factors |
| 10 | Symptomatology |
| 10 | Survival Rate |
| 10 | Sarcoma |
| 10 | Primitive |
| 10 | Microsurgery (methods) |
| 10 | Medicine |
| 10 | Lymphedema (prevention & control) |
| 10 | Lymph node |
| 10 | Lymph Nodes (pathology) |
| 10 | Iatrogenic |
| 10 | Evolution |
| 10 | Elephantiasis, Filarial (parasitology) |
| 10 | Edema |
| 10 | Cancerology |
| 10 | Biopsy |
| 10 | Antineoplastic Combined Chemotherapy Protocols (therapeutic use) |
| 9 | Venous incompetence |
| 9 | Surgical Flaps |
| 9 | Skin (pathology) |
| 9 | Sensitivity and Specificity |
| 9 | Pressure |
| 9 | Lymphography |
| 9 | Lymphedema (epidemiology) |
| 9 | Lymphedema (congenital) |
| 9 | Lymphedema (chemically induced) |
| 9 | Lymphangiectasis |
| 9 | Lymph Node Excision |
| 9 | Lipoedema |
| 9 | Hand |
| 9 | Extremities |
| 9 | Etiology |
| 9 | Clinical management |
| 8 | Yellow nail syndrome |
| 8 | Scrotum |
| 8 | Rheumatology |
| 8 | Radiography |
| 8 | Quality of life |
| 8 | Quality of Life |
| 8 | Primary |
| 8 | Pregnancy |
| 8 | Phenotype |
| 8 | Penis |
| 8 | Mastectomy (adverse effects) |
| 8 | Manuals |
| 8 | Magnetic Resonance Imaging |
| 8 | Leg (pathology) |
| 8 | Elephantiasis, Filarial (diagnosis) |
| 8 | Classification |
| 7 | Surveys and Questionnaires |
| 7 | Secondary |
| 7 | Postoperative Complications (epidemiology) |
| 7 | Neoplasm Recurrence, Local |
| 7 | Lymphedema (drug therapy) |
| 7 | Lymphadenectomy |
| 7 | Lymph Nodes (diagnostic imaging) |
| 7 | France (epidemiology) |
| 7 | Eyelashes (abnormalities) |
| 7 | Elephantiasis, Filarial (epidemiology) |
| 7 | Elastic bandage |
| 7 | Cohort Studies |
| 7 | Bandage |
| 7 | Association |
| 6 | Survival Analysis |
| 6 | Substance Abuse, Intravenous (complications) |
| 6 | Sentinel Lymph Node Biopsy |
| 6 | Recurrence |
| 6 | Radiotherapy Dosage |
| 6 | Postoperative Complications |
| 6 | Pain (etiology) |
| 6 | Obesity (complications) |
| 6 | Neoplasms (complications) |
| 6 | Mutation |
| 6 | Mastectomy, Segmental |
| 6 | Lymphocele (etiology) |
| 6 | Lymphangiosarcoma |
| 6 | Lymph Nodes (surgery) |
| 6 | Incidence |
| 6 | Gynecology |
| 6 | Fatal Outcome |
| 6 | Erysipelas (etiology) |
| 6 | Epidemiology |
| 6 | Echography |
| 6 | Differential diagnostic |
| 6 | Computerized axial tomography |
| 6 | Carcinoma |
| 6 | Bibliographic review |
| 6 | Anastomosis, Surgical (methods) |
| 5 | Yellow Nail Syndrome (diagnosis) |
| 5 | Wuchereria bancrofti |
| 5 | Wuchereria bancrofti (isolation & purification) |
| 5 | Venous disease |
| 5 | Venotropic agent |
| 5 | Ultrasonography |
| 5 | Tumor |
| 5 | Surveillance |
| 5 | Stockings, Compression |
| 5 | Stewart Treves syndrome |
| 5 | Skin Neoplasms (surgery) |
| 5 | Skin Neoplasms (diagnosis) |
| 5 | Sentinel lymph node |
| 5 | Result |
| 5 | Reproducibility of Results |
| 5 | Relapse |
| 5 | Reeducation |
| 5 | Radiotherapy (adverse effects) |
| 5 | Public health |
| 5 | Postoperative Complications (diagnosis) |
| 5 | Pilot Projects |
| 5 | Pedigree |
| 5 | Pathogenesis |
| 5 | Nuclear magnetic resonance imaging |
| 5 | Melanoma (surgery) |
| 5 | Lymphedema (classification) |
| 5 | Lymphatic Vessels (surgery) |
| 5 | Lymphatic System (physiology) |
| 5 | Lymphangitis |
| 5 | Lymphangiosarcoma (pathology) |
| 5 | Lymphangiosarcoma (diagnosis) |
| 5 | Lymphangiectasis, Intestinal (diagnosis) |
| 5 | Lung |
| 5 | Infection |
| 5 | Hemangiosarcoma (pathology) |
| 5 | Head and neck |
| 5 | Exercise Therapy |
| 5 | Endometrial Neoplasms (surgery) |
| 5 | Elephantiasis, Filarial (transmission) |
| 5 | Elephantiasis, Filarial (complications) |
| 5 | Edema (etiology) |
| 5 | Double-Blind Method |
| 5 | Compressive bandage |
| 5 | Combined treatment |
| 5 | Circulatory system |
| 5 | Blood vessel |
| 5 | Anti-Bacterial Agents (therapeutic use) |
| 5 | Analysis of Variance |
| 4 | erysipelas |
| 4 | breast cancer |
| 4 | Yellow Nail Syndrome (complications) |
| 4 | Vein |
| 4 | Uterine Cervical Neoplasms (surgery) |
| 4 | Upper Extremity |
| 4 | Upper Extremity (surgery) |
| 4 | Tropical medicine |
| 4 | Toxicity |
| 4 | Telangiectasis (etiology) |
| 4 | Soft tissue |
| 4 | Skin disease |
| 4 | Skin Neoplasms (drug therapy) |
| 4 | Sirolimus (adverse effects) |
| 4 | Signal Transduction |
| 4 | Risk Assessment |
| 4 | Reference Values |
| 4 | Reconstructive Surgical Procedures (methods) |
| 4 | Radionuclide study |
| 4 | Obesity |
| 4 | Neoplasm Recurrence, Local (surgery) |
| 4 | Neoplasm Metastasis |
| 4 | Morbidity |
| 4 | Microsurgery |
| 4 | Mice |
| 4 | Mammaplasty (methods) |
| 4 | Lymphoma |
| 4 | Lymphocele (epidemiology) |
| 4 | Lymphedema (rehabilitation) |
| 4 | Lymphatic circulation |
| 4 | Lymphatic Metastasis (diagnosis) |
| 4 | Lymphangiectasis, Intestinal (complications) |
| 4 | Lower Extremity |
| 4 | Lipectomy |
| 4 | Leg (surgery) |
| 4 | Leg (diagnostic imaging) |
| 4 | Kinesitherapist |
| 4 | Instrumentation therapy |
| 4 | Immunohistochemistry |
| 4 | Hemangiosarcoma (diagnosis) |
| 4 | Hand (pathology) |
| 4 | Gerontology |
| 4 | Genetic disease |
| 4 | Forkhead Transcription Factors (genetics) |
| 4 | Foot |
| 4 | Flavonoid |
| 4 | Fibrosis |
| 4 | Feasibility Studies |
| 4 | Family study |
| 4 | Face |
| 4 | Erysipelas (prevention & control) |
| 4 | Erysipelas (epidemiology) |
| 4 | Equipment Design |
| 4 | Elephantiasis |
| 4 | Elephantiasis, Filarial (prevention & control) |
| 4 | Effusion |
| 4 | Drug addiction |
| 4 | Distichiasis |
| 4 | Disease-Free Survival |
| 4 | Disease Progression |
| 4 | DNA Mutational Analysis |
| 4 | Cross-Sectional Studies |
| 4 | Compression Bandages |
| 4 | Comparative study |
| 4 | Clinical investigation |
| 4 | Chemotherapy, Adjuvant |
| 4 | Cellulitis |
| 4 | Cardiology |
| 4 | Carcinoma, Ductal, Breast (radiotherapy) |
| 4 | Breast Neoplasms (psychology) |
| 4 | Breast Neoplasms (mortality) |
| 4 | Bacteriosis |
| 4 | Antineoplastic agent |
| 4 | Antibiotic |
| 4 | Anatomy |
| 4 | Anastomosis, Surgical |
| 4 | Abnormalities, Multiple (genetics) |
| 4 | Abdomen |
| 3 | Weight Loss |
| 3 | Volumetric analysis |
| 3 | Venules (surgery) |
| 3 | Vascular Endothelial Growth Factor Receptor-3 (genetics) |
| 3 | Varicose Veins (surgery) |
| 3 | Uterine Cervical Neoplasms (pathology) |
| 3 | Unilateral |
| 3 | Ultrasonography, Prenatal |
| 3 | Tumor Suppressor Proteins (genetics) |
| 3 | Transplantation, Autologous |
| 3 | Thrombosis |
| 3 | Surgical resection |
| 3 | Surgical Wound Dehiscence (etiology) |
| 3 | Surgical Flaps (blood supply) |
| 3 | Suction |
| 3 | Statistics, Nonparametric |
| 3 | Skin Ulcer (etiology) |
| 3 | Skin Neoplasms (diagnostic imaging) |
| 3 | Skin Diseases (pathology) |
| 3 | Skin Diseases (diagnosis) |
| 3 | Skin Care |
| 3 | Sex Factors |
| 3 | Sex Distribution |
| 3 | Retrospective |
| 3 | Reoperation |
| 3 | Remission Induction |
| 3 | Recommendation |
| 3 | Rats |
| 3 | Randomized Controlled Trials as Topic |
| 3 | Radiotherapy, Adjuvant (adverse effects) |
| 3 | Radiation Injuries (etiology) |
| 3 | Quantitative analysis |
| 3 | Program Evaluation |
| 3 | Postoperative Complications (therapy) |
| 3 | Postoperative Complications (surgery) |
| 3 | Pleura |
| 3 | Pediatrics |
| 3 | Patient Selection |
| 3 | Patient Education as Topic |
| 3 | Pain |
| 3 | Odds Ratio |
| 3 | Obstetrics |
| 3 | Nutritional status |
| 3 | Noonan Syndrome (complications) |
| 3 | Neoplasm Recurrence, Local (pathology) |
| 3 | Neoadjuvant Therapy |
| 3 | Necrosis |
| 3 | Neck |
| 3 | Nail(anatomy) |
| 3 | Nail Diseases (etiology) |
| 3 | Nail Diseases (complications) |
| 3 | Mutation, Missense |
| 3 | Multivariate Analysis |
| 3 | Multicenter study |
| 3 | Models, Biological |
| 3 | Microfilariae (isolation & purification) |
| 3 | Melanoma (pathology) |
| 3 | Mastectomy, Segmental (adverse effects) |
| 3 | Mastectomy (methods) |
| 3 | Mammary gland diseases |
| 3 | Lymphography (methods) |
| 3 | Lymphedema (psychology) |
| 3 | Lymphatic System (surgery) |
| 3 | Lymphatic System (pathology) |
| 3 | Lymphatic System (anatomy & histology) |
| 3 | Lymphatic Irradiation (adverse effects) |
| 3 | Lymphatic Diseases (complications) |
| 3 | Lymphangiosarcoma (drug therapy) |
| 3 | Lymphangioma (pathology) |
| 3 | Lymphangiogenesis (physiology) |
| 3 | Lymphangiogenesis (genetics) |
| 3 | Lymphangiectasis, Intestinal (pathology) |
| 3 | Lymphangiectasis, Intestinal (genetics) |
| 3 | Lymphangiectasis (pathology) |
| 3 | Lymph node metastasis |
| 3 | Lung Diseases (diagnosis) |
| 3 | Long term |
| 3 | Logistic Models |
| 3 | Length of Stay |
| 3 | Leg Length Inequality (etiology) |
| 3 | Leg (anatomy & histology) |
| 3 | Laparoscopy |
| 3 | Kidney Transplantation |
| 3 | Kaposi sarcoma |
| 3 | Irradiation |
| 3 | Intellectual Disability (genetics) |
| 3 | Insect Vectors (parasitology) |
| 3 | Inguinal |
| 3 | Inaugural sign |
| 3 | In Situ Hybridization, Fluorescence |
| 3 | Immunosuppressive Agents (adverse effects) |
| 3 | Image Processing, Computer-Assisted |
| 3 | Iatrogenic Disease |
| 3 | Hyposalivation |
| 3 | Hygiene |
| 3 | Hydrops Fetalis (genetics) |
| 3 | Hospitalization |
| 3 | Health Surveys |
| 3 | Head and Neck Neoplasms (pathology) |
| 3 | Gut |
| 3 | Groin |
| 3 | Genetic determinism |
| 3 | Genetic Predisposition to Disease |
| 3 | Fever |
| 3 | Extremities (pathology) |
| 3 | Exeresis |
| 3 | Evaluation |
| 3 | Endoscopy |
| 3 | Endometrial Neoplasms (pathology) |
| 3 | Endemic Diseases (prevention & control) |
| 3 | Elephantiasis, Filarial (history) |
| 3 | Drug Administration Schedule |
| 3 | Drainage (methods) |
| 3 | Disease |
| 3 | Diosmin |
| 3 | Dermatocellulitis |
| 3 | Debridement |
| 3 | Cyclophosphamide (administration & dosage) |
| 3 | Culex (parasitology) |
| 3 | Craniofacial Abnormalities (genetics) |
| 3 | Conservative surgery |
| 3 | Consanguinity |
| 3 | Confidence Intervals |
| 3 | Concomitant disease |
| 3 | Clinical form |
| 3 | Clinical Protocols |
| 3 | Chromosome Deletion |
| 3 | Chemoradiotherapy (adverse effects) |
| 3 | Cellulitis (etiology) |
| 3 | Cellulitis (complications) |
| 3 | Carcinoma, Lobular (surgery) |
| 3 | Carcinoma, Lobular (radiotherapy) |
| 3 | Carcinoma, Ductal, Breast (therapy) |
| 3 | Carcinoma, Ductal, Breast (surgery) |
| 3 | Carcinoma, Ductal, Breast (pathology) |
| 3 | Breast Neoplasms (diagnostic imaging) |
| 3 | Brachytherapy |
| 3 | Body Mass Index |
| 3 | Arm (surgery) |
| 3 | Antineoplastic Combined Chemotherapy Protocols (adverse effects) |
| 3 | Antineoplastic Agents (adverse effects) |
| 3 | Antineoplastic Agents (administration & dosage) |
| 3 | Anthelmintics (therapeutic use) |
| 3 | Ambulatory |
| 3 | Age of Onset |
| 3 | Africa |
| 3 | Adjuvant treatment |
| 3 | Acute Disease |
| 2 | yellow nail syndrome |
| 2 | microcirculation |
| 2 | Yellow Nail Syndrome (therapy) |
| 2 | Yellow Nail Syndrome (etiology) |
| 2 | Wuchereria bancrofti (growth & development) |
| 2 | Wound |
| 2 | World Health Organization |
| 2 | Woman |
| 2 | Vulvar Neoplasms (surgery) |
| 2 | Vulvar Neoplasms (pathology) |
| 2 | Volume |
| 2 | Venous Insufficiency (complications) |
| 2 | Vascular Surgical Procedures |
| 2 | Vascular Surgical Procedures (methods) |
| 2 | Vascular Endothelial Growth Factor C |
| 2 | Varix |
| 2 | Uterine Cervical Neoplasms (therapy) |
| 2 | Uterine Cervical Neoplasms (psychology) |
| 2 | Urine |
| 2 | Ultrasound |
| 2 | Turner syndrome |
| 2 | Treatment Failure |
| 2 | Travel |
| 2 | Trauma |
| 2 | Transcription Factors (genetics) |
| 2 | Tomography, Emission-Computed, Single-Photon |
| 2 | Telangiectasia |
| 2 | Technetium Tc 99m Sulfur Colloid |
| 2 | Taxoids (therapeutic use) |
| 2 | Survivors |
| 2 | Survey |
| 2 | Surgical Wound Infection (etiology) |
| 2 | Surgery, Plastic |
| 2 | Squamous cell carcinoma |
| 2 | Sonography |
| 2 | Somatostatin (analogs & derivatives) |
| 2 | Soft Tissue Neoplasms (surgery) |
